138 related articles for article (PubMed ID: 9861336)
21. Future directions in the treatment of squamous cell carcinoma of the head and neck: the role of UFT.
Colevas AD
Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):86-9. PubMed ID: 9348576
[TBL] [Abstract][Full Text] [Related]
22. [Chemosensitivity of head and neck squamous cell carcinomas using subrenal capsule assay--comparative assay of 5-FU, FT, UFT, and HCFU and immunohistochemical study].
Nakashima T; Miyagi M; Kusumoto T
Nihon Jibiinkoka Gakkai Kaiho; 1992 Jan; 95(1):95-103. PubMed ID: 1545316
[TBL] [Abstract][Full Text] [Related]
23. [A case of laryngeal cancer treated for over 2 years with UFT and CBDCA alone].
Iwasaki K; Oida I; Usami A; Hashimoto Y; Yamada M; Ozawa T
Gan To Kagaku Ryoho; 1999 Feb; 26(3):369-72. PubMed ID: 10065103
[TBL] [Abstract][Full Text] [Related]
24. Characterization of a novel lymph node metastasis model from human colonic cancer and its preclinical use for comparison of anti-metastatic efficacy between oral S-1 and UFT/ LV.
Ito Y; Nakanishi H; Kodera Y; Hirai T; Nakao A; Kato T
Cancer Sci; 2010 Aug; 101(8):1853-60. PubMed ID: 20500514
[TBL] [Abstract][Full Text] [Related]
25. A cost comparison of oral tegafur plus uracil/folinic acid and parenteral fluorouracil for colorectal cancer in Canada.
Maroun J; Asche C; Romeyer F; Mukherjee J; Cripps C; Oza A; Skillings J; Letarte J
Pharmacoeconomics; 2003; 21(14):1039-51. PubMed ID: 13129416
[TBL] [Abstract][Full Text] [Related]
26. Effects of oral UFT combined with or without zoledronic acid on bone metastasis in the 4T1/luc mouse breast cancer.
Hiraga T; Ueda A; Tamura D; Hata K; Ikeda F; Williams PJ; Yoneda T
Int J Cancer; 2003 Oct; 106(6):973-9. PubMed ID: 12918079
[TBL] [Abstract][Full Text] [Related]
27. [Relationship between the anti-metastatic effect of UFT and in vitro chemosensitivity to 5-FU in metastatic tumors from orthotopic implanted colon cancer in nude rats].
Ogata Y; Akagi Y; Nozoe Y; Sasatomi T; Miyagi Y; Nakagawa M; Matono K; Kobayashi H; Shirouzu K
Gan To Kagaku Ryoho; 2001 May; 28(5):655-60. PubMed ID: 11383214
[TBL] [Abstract][Full Text] [Related]
28. [The serum and tissue concentrations of tegafur, 5-fluorouracil and uracil in patients with gastric and colorectal cancers after oral administration of UFT].
Takahashi N; Nitta A; Saitou T; Mori Y; Kunii Y; Kikuchi K
Gan To Kagaku Ryoho; 1988 Aug; 15(8):2319-23. PubMed ID: 3136701
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant effects of calmodulin antagonists on antitumor activity of 1-(2-tetrahydrofuryl)-5-fluorouracil (ftorafur) and a mixture of ftorafur and uracil (UFT) in nude mice bearing human ovarian carcinomas.
Kikuchi Y; Oomori K; Iwano I; Kizawa I; Miyauchi M; Kita T; Kuki E
Gynecol Oncol; 1989 Nov; 35(2):172-6. PubMed ID: 2509301
[TBL] [Abstract][Full Text] [Related]
30. Circadian variations in the pharmacokinetics of the oral anticancer agent tegafur-uracil (UFT) and its metabolites in rats.
Kobuchi S; Ito Y; Takamatsu D; Sakaeda T
Eur J Pharm Sci; 2018 Oct; 123():452-458. PubMed ID: 30077713
[TBL] [Abstract][Full Text] [Related]
31. 5-Fluorouracil incorporated into the tissue RNA of human and rat bladder carcinoma after administration of 1-(2-tetrahydrofuryl)-5-fluorouracil combined with uracil.
Tsujimoto S; Fujimoto K; Okajima E; Ozono S; Okajima E; Hirao Y
Int J Clin Oncol; 2008 Apr; 13(2):138-43. PubMed ID: 18463958
[TBL] [Abstract][Full Text] [Related]
32. Predictive value of immunohistochemical thymidylate synthase expression for histological response to Tegafur/Uracil (UFT) in oral squamous cell carcinoma.
Kawano K; Goto H; Kanda T; Yanagisawa S
Int J Oral Maxillofac Surg; 2003 Dec; 32(6):633-7. PubMed ID: 14636615
[TBL] [Abstract][Full Text] [Related]
33. Clinical basis of chemotherapy for gastric cancer with uracil and 1-(2'-tetrahydrofuryl)-5-fluorouracil.
Kimura K; Suga S; Shimaji T; Kitamura M; Kubo K; Suzuoki Y; Isobe K
Gastroenterol Jpn; 1980; 15(4):324-9. PubMed ID: 6773844
[TBL] [Abstract][Full Text] [Related]
34. [5-FU concentration in blood and tissue of patients with primary lung cancer after oral administration of UFT].
Oiwa T; Saito H
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):525-30. PubMed ID: 3082289
[TBL] [Abstract][Full Text] [Related]
35. Antitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats.
Shirasaka T; Nakano K; Takechi T; Satake H; Uchida J; Fujioka A; Saito H; Okabe H; Oyama K; Takeda S; Unemi N; Fukushima M
Cancer Res; 1996 Jun; 56(11):2602-6. PubMed ID: 8653704
[TBL] [Abstract][Full Text] [Related]
36. [A case of multiple lymph node metastases from transverse colon cancer successfully treated with oral tegafur/uracil (UFT)/Leucovorin (LV)].
Tomimaru Y; Ide Y; Murata K
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2165-7. PubMed ID: 19106558
[TBL] [Abstract][Full Text] [Related]
37. Plasma, intestine and tumor levels of 5-fluorouracil in mice bearing L1210 ascites tumor following oral administration of 5-fluorouracil, UFT (mixed compound of tegafur and uracil), carmofur and 5'-deoxy-5-fluorouridine.
Ooi A; Ohkubo T; Higashigawa M; Kawasaki H; Kakito H; Kagawa Y; Kojima M; Sakurai M
Biol Pharm Bull; 2001 Nov; 24(11):1329-31. PubMed ID: 11725974
[TBL] [Abstract][Full Text] [Related]
38. 5-Ethynyluracil (776C85): effects on the antitumor activity and pharmacokinetics of tegafur, a prodrug of 5-fluorouracil.
Cao S; Baccanari DP; Joyner SS; Davis ST; Rustum YM; Spector T
Cancer Res; 1995 Dec; 55(24):6227-30. PubMed ID: 8521418
[TBL] [Abstract][Full Text] [Related]
39. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
[TBL] [Abstract][Full Text] [Related]
40. [Effect of calmodulin antagonists (W-5 and W-7) on antitumor activity of Tegafur and UFT (Tegafur plus uracil)].
Kikuchi Y; Oomori K; Iwano I; Kizawa I; Miyauchi M; Kita T; Kato K
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Apr; 40(4):422-8. PubMed ID: 3131462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
